I hope Insmed makes a run at the top 10. Most of them have had amazing runs on the back of "ignorant" short sellers. Insmed short interest and accompanying volume is unprecedented. Good things are in store. pianoman
P.S. SRPT is 40 bucks a share!!!
Sentiment: Strong Buy
Which is why short interest is hardly ever an indicator of the drug's performance.
"hardly ever an indicator of the drug's performance"....ahh ... Insmed has a couple years wait...and in the meantime,,,Good Luck